Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention.

导出原文传递

翻译打印收藏纠错

第一作者： Pei,Zhu

第一单位： Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, The Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China.

作者： Pei,Zhu ^[1] ; Xiao-Fang,Tang ^[1] ; Jing-Jing,Xu ^[1] ; Ying,Song ^[1] ; Ru,Liu ^[1] ; Yin,Zhang ^[1] ; Lijian,Gao ^[1] ; Zhan,Gao ^[1] ; Jue,Chen ^[1] ; Yue-Jin,Yang ^[1] ; Run-Lin,Gao ^[1] ; Bo,Xu ^[1] ; Jin-Qing,Yuan ^[1]

作者单位： Department of Cardiology, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, The Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing , China. ^[1]

关键词 Chronic kidney disease dual antiplatelet therapy percutaneous coronary intervention platelet reactivity

主题词血小板(Blood Platelets);女(雌)性(Female);人类(Humans);男(雄)性(Male);血小板聚集抑制剂(Platelet Aggregation Inhibitors);肾功能不全, 慢性(Renal Insufficiency, Chronic)

DOI 10.1080/09537104.2018.1549319

PMID 30518271

发布时间 2020-01-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交